PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
AID  - 10.1136/jitc-2021-004291corr1
DP  - 2022 Jun 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004291corr1
VI  - 10
IP  - 6
4099  - http://jitc.bmj.com/content/10/6/e004291corr1.short
4100  - http://jitc.bmj.com/content/10/6/e004291corr1.full
SO  - J Immunother Cancer2022 Jun 01; 10